{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"EIF1AX, a translation initiation factor, is most frequently altered by mutation in uveal melanomas and papillary thyroid carcinomas.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"03/07/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "24265153",
        "30305285"
      ]
    },
    "description":"The EIF1AX G8R mutation is located in the N-terminal-tail domain of the protein. This mutation has been identified in malignant melanoma and is a statistically significant hotspot (PMID: 24265153). In vitro studies with NthyOri cells expressing EIF1AX G8R demonstrate that the mutation is activating as measured by an increase in nascent protein synthesis compared to wildtype (PMID: 30305285).",
    "knownEffect":"Likely Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"G8R",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":1964,
    "hgvs":null,
    "hugoSymbol":"EIF1AX",
    "id":null,
    "proteinEnd":8,
    "proteinStart":8,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The EIF1AX G8R mutation is likely oncogenic.",
  "vus":false
}